MANGOCEUTICALS, INC. Quarterly Liabilities and Equity in USD from Q4 2022 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary: Mangoceuticals, Inc. quarterly Liabilities and Equity history and growth rate from Q4 2022 to Q3 2024.
Mangoceuticals, Inc. Liabilities and Equity for the quarter ending September 30, 2024 was $14.8M, a 827% increase year-over-year.

Liabilities and Equity, Quarterly (USD)

Liabilities and Equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$14.8M	+$13.2M	+827%	Sep 30, 2024	10-Q	2024-11-14
Q2 2024	$15.2M	+$11.9M	+362%	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$301K	-$3.81M	-92.7%	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$1.05M	+$47.5K	+4.74%	Dec 31, 2023	10-Q	2024-11-14
Q3 2023	$1.6M			Sep 30, 2023	10-Q	2023-10-27
Q2 2023	$3.3M			Jun 30, 2023	10-Q	2023-07-28
Q1 2023	$4.12M			Mar 31, 2023	10-Q	2023-05-10
Q4 2022	$1M			Dec 31, 2022	10-K	2024-04-01

* An asterisk sign (*) next to the value indicates that the value is likely invalid.